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The perturbation status of vitamin D can be manifested as insufficiency, deficiency 
and excessiveness. Vitamin D status within the organism is determined by measuring 
the level of 25(OH)D in the serum.  
The aim of this paper was to determine the vitamin D status in postmenopausal 
women with newly diagnosed osteoporosis as well as to correlate vitamin D status with 
bone mineral density (BMD) and bones' fractures.  
The research included 58 postmenopausal women who have recently been given the 
diagnosis of postmenopausal osteoporosis. All the examinees were determined with the 
level of 25(OH)D as well as the levels of unspecific markers of the bone metabolism. All 
of the examinees were defined with their bone mineral density on the lumbar spine and 
hip, measured with DEXA densitometer.  
The average age of the examinees was 60,46±6,55 years, average duration of 
menopause 15,02±9,25 years and average concentration of 25(OH)D 46,45±14,68 
nmol/L. Our results has shown the deficiency of vitamin D in 89,76% of the examinees 
with postmenopausal osteoporosis, positive correlation of the level of 25(OH)D and bone 
mineral density (BMD) and a significantly lower initial concentration of 25(OH)D with the 
examines with prior bone fractures opposed to those without fractures (37,57±13,08 vs.  
51,22±17,26 nmol/L; p<0,02). 
The obtained results show that vitamine D deficiency in postmenopausal women 
with osteporosis present important risk factors for bones fractures as well as factors for 
decreasing the bone mineral density. Acta Medica Medianae 2010;49(4):16-18. 
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Introduction 
 
Vitamin D, its active metabolites and analogues 
represent the group of compounds with numerous 
functions within the organism. The primary role 
of vitamin D is in the metabolism of phosphorus 
and calcium. It is well-known that vitamin D 
increases intestinal and tubular absorption of 
calcium. Nowadays, it is also known that vitamin 
D decreases the physiological activity of para-
thormon (PTH) in the following ways: directly, by 
affecting parathyroid glands, and also indirectly 
by hypercalcemia (1). It is also known that 
vitamin D helps with bone formation. Affecting 
the osteoblasts via vitamin D receptors (VDR) 
increases the synthesis of osteoclacin, alkaline 
phosphatase (ALP) and the collagen type I. The 
effect of vitamin D on osteoclasts is double: 
indirect – via osteoblasts (RANKL/RANK/osteoprote-
gerin system), and directly – by suppression of 
differentiation from promyelocytes to monocytes, 
that are the precursors of osteoclasts (2). By 
regulation of calcium metabolism in muscle cells, 
vitamin D affects the muscle tissue which is 
significant for the process of contraction and 
relaxation of muscle fibers (3). Besides endocrine 
function, vitamn D has numerous paracrine 
functions which it achieves by controlling over 
200 genes, including genes responsible for the 
regulation of mineralization process, the differen-
iation of cells, and regulation of apoptosis and 
angiogenesis process (4). The status perturbation 
of vitamin D can be manifested as insufficiency, 
deficiency and excessiveness. Risk factors for 
insufficiency of vitamin D are: nourishment 
disorder, life style (sun exposure less than 15 
minutes per day, old age and occult malab-
rption, kidney and liver function disorder as well 
as the mutation of VDR (rare risk factors). 
Vitamin D status within the organism is deter-
ined by measuring the level of 25(OH)D in the 
serum (5). Acta Medica Medianae 2010, Vol.49(4)                                             Vitamin D status in women with postmenopausal osteoporosis 
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Aim 
 
The aim of this research was to determine 
the status of vitamin D in women that have been 
recently given the diagnosis of postmenopausal 
osteoporosis and to correlate the status of 
vitamin D with bone mineral density (BMD) and 
previous fractures. 
 
Patients and methods 
 
  The research included 58 women who have 
recently been given the diagnosis of post-
nopausal osteoporosis and who had not taken 
vitamin D as prevention of osteoporosis. All the 
examinees were determined with the level of 
25(OH)D as well as the level of calcium, phos-
horus and alkaline phosphatase in serum and 
also level of calcium and phosphorous in 24h old 
urine. The level of 25(OH)D were determined by 
ELISA method. All of the examinees were defined 
with their bone mineral density on the lumbar 
spine and hip, measured with dual energy x-ray 
absorptiometry on the Holgic Discovery machine. 
Obtained results were further analyzed by 
Pearson and Spearman’s correlation test and 
student T-test. 
 
Results 
 
Average age of the examinees was 
60,46±6,55, average duration of menopause was 
15,02±9,25 years and average value of 25(OH)D 
was 46,45±14,68nmol/L. With all examinees the 
level of Ca,P and ALP in Serum and level of Ca 
and P in 24h old urine were in reference limits. 
Insufficiency of vitamin D was determined in 52 
(89,76%) of the examinees. We determined the 
existence of positive correlation level of 25(OH)D 
and BMD or T-score on lumbar spine (L1-L4), 
(46,45±14,68nmol/L vs. 0,718±0,06g/cm² and 
46,45±14,68nmol/L vs.-2,98±0,56; p<0,05, r=0.375) 
(Table 1). 
 
Table 1. Correlation level of 25(OH)D and BMD or T-
score 
 
 
Table 2. The level of 25(OH)D in the examinees with 
previous fractures and those with no fractures 
 
 
Number 
of 
patients 
Level 25 
(OH)D 
(U/I) 
 
with 
fractures 
with no 
fractures 
18 
40 
37,57±13,08 
51,22±17,26 
p<0,02 
 
Statistically significant difference of the 
level of 25(OH)D was determined in the 
examinees with previous fractures (n=18) in 
comparison to those with no fractures (n=40) 
(37,57±13,08 vs. 51,22±17,26nmol/L; p<0,02) 
(Table 2). 
 
Discussion 
 
In 1985, Peacock et al. gave the definition 
of vitamin D as a concentration of 25(OH)D 
within the serum in which there is the formation 
of secondary hyperparathyroidism and there is 
the reduction of bone mineral density (6). Since 
2005, the deficiency of vitamin D is defined as 
the level of 25(OH)D in the serum lower than 75 
nmol/l (30ng/ml), while heavy insufficiency of 
vitamin D as the level of 25 (OH)D lower than 
25nmol/l (10ng/ml). It is considered that the 
normal status of vitamin D is when the level of 
25(OH)D within the serum is over 75nmol (30 
ng/ml) (7). There are numerous studies in which 
a large prevalence of deficiency of vitamin D with 
postmenopausal women was proven, unless it is 
“cut off” by 25(OH)D 75 nmol/l. The OFELY study 
that included 669 postmenopausal women, with 
the average age of 62.2 has shown that 73% of 
the examinees had the average concentration of 
25(OH)D lower than 75nmol/l (8). Kuchuk NO, 
van Schoor NM et al. published their results that 
had been conducted in 29 countries and included 
7.441 postmenopausal women. The results 
showed that the average concentration of 
25(OH)D within the serum in examinees was 
61,2nmol/l (9). Lips P. et al. showed in their 
study, which included 2.589 women with postmeno-
pausal osteoporosis, that the prevalence of 
insufficiency of vitamin D by regions is distributed 
from 53,4% to 81.8%. Preliminary results of the 
pilot  study  in  four centers in Serbia have shown 
vitamin D insufficiency in 95% women with 
postmenopausal osteoporosis (10). Our research, 
which included significantly lower number of 
patients, has shown the deficiency of vitamin D in 
89,76% of the examinees. The results of our 
investigation have also shown a positive 
correlation of the level of 25(OH)D and bone 
mineral density (BMD) or T-score of lumbal spine 
which is in accordance with the results of a large 
number of studies that have confirmed the 
existence of this correlation. In 2005, Bischof-
Ferrari HA et al. showed  in metha- analysis of 
four randomized studies of the hip fractures 
(9.294 examinees) and in seven randomized 
studies of nonvertebral fractures (9.820 examinees) 
that the concentration of 25(OH)D within the 
serum is very important for the anti-fracture 
efficiency of vitamin D. It was determined that 
the optimal concentration for fracture prevention 
of 25(OH)D within the serum is 75-100nmol/l 
(11). However, 2005 RECORD study, which 
included 5.000 examinees over 70 years old 
25(OH)D 
(nmol/L) 
46,45±14,68 
BMD (g/cm²) 
0,718±0,06 
p<0,05 r=0,375 
25(OH)D 
(nmol/L) 
46,45±14,68 
T-score 
-2,98±0,56 
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(12), and 2006 WHI study that included 36.000 
examinees, did not find anti-fracture activity of 
vitamin D (13). With some additional analyses it 
was determined why there was a disaccord in 
previously mentioned researches and it was proved 
that the initial concentration of 25(OH) within the 
serum was very important for the anti-fracture 
efficiency of vitamin D. The results of our research 
showed a significantly lower initial concentration of 
25(OH)D with the examinees with previous 
fractures compared to those without  fractures. 
 
Conclusion 
  
Our results show that the deficiency of vitamin 
D in women with postmenopausal osteoporosis 
poses a significant risk factor for bone fractures 
and decrease of bone mineral density (BMD).  
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STATUS VITAMINA D KOD ŽENA SA POSTMENOPAUZALNOM 
OSTEOPOROZOM 
 
Saša Milenković, Aleksandar Dimić, Aleksandra Stanković, Ivana Aleksić i Dejan Petrović 
 
 
  Poremećaj statusa vitamina D može se manifestovati kao insuficijencija (nedostatak), 
nedovoljnost (deficijencija) i hipervitaminoza. Status vitamina D u organizmu određuje se 
merenjem nivoa 25(OH)D u serumu.  
Cilj našeg rada bio je da kod žena sa novodijagnostikovanom postmenopauzalnom 
osteoporozom odredimo status vitamina D kao i da koreliramo status vitamina D sa 
mineralnom koštanom gustinom (BMD) i prethodnim frakturama. 
Ispitivanje je obuhvatilo 58 žena sa novodijagnostikovanom  postmenopauzalnom 
osteoporozom. Svim ispitanicama su određivani nivoi 25(OH)D kao i nivoi nespecifičnih 
markera koštanog metabolizma. Svim ispitanicama određivana je i koštana mineralna 
gustina na lumbalnoj kičmi i kuku DEXA denzitometrom. 
Prosečna starost ispitanica bila je 60,46±6,55 godina, prosečno trajanje menopauze 
15,02±9,25 godina i prosečna vrednost 25(OH)D 46,45±14,68nmol/l. Naši rezultati su 
pokazali nedovoljnost vitamina D kod 89,76% ispitanica sa postmenopauzalnom 
osteoporozom, pozitivnu korelaciju nivoa 25(OH)D i mineralne koštane gustine (BMD) i 
značajno nižu početnu koncentraciju 25(OH)D kod ispitanica sa prethodnim frakturama u 
odnosu na one bez fraktura (37,57±13,08 vs. 51,22±17,26nmol/l; p<0,02). 
Naši rezultati pokazuju da nedovoljnost vitamina D kod žena sa postmenopauzalnom 
osteoporozom predstavlja značajan faktor rizika za nastanak fraktura, kao i faktor koji 
doprinosi smanjenju mineralne koštane gustine. Acta Medica Medianae 2010;49(4):16-18. 
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